Advertisement
Screener

AUXILIUM PHARMACEUTICALS INC Financing Cash Flow

AUXILIUM PHARMACEUTICALS INC Financing Cash Flow

AUXILIUM PHARMACEUTICALS INC reported Financing Cash Flow of $1.96 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-05-10

  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $1.96M, a 258.61% increase year-over-year.
  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $1.41M, a 2.29% decline year-over-year.
  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $300.00K.
  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-06-30 was $1.53M, a 52.09% decline year-over-year.
  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2011 was $3.79M, a 33.17% decline from fiscal 2010.
  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2010 was $5.67M, a 95.27% decline from fiscal 2009.
  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2009 was $119.99M, a 1602.98% increase from fiscal 2008.
  • AUXILIUM PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2008 was $7.05M.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2012-03-31$1.96M
10-Q · filed 2012-05-10
$3.37M
derived: sum of 2 quarters · filed 2012-05-10
$3.67M
derived: sum of 3 quarters · filed 2012-05-10
$5.20M
derived: sum of 4 quarters · filed 2012-05-10
2011-12-31$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$1.71M
derived: sum of 2 quarters · filed 2012-02-29
$3.25M
derived: sum of 3 quarters · filed 2012-02-29
$3.79M
10-K · filed 2012-02-29
2011-09-30$300.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$1.83M
derived: sum of 2 quarters · filed 2011-11-09
$2.38M
10-Q · filed 2011-11-09
$3.83M
derived: sum of 4 quarters · filed 2012-05-10
2011-06-30$1.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02
$2.08M
10-Q · filed 2011-08-02
$3.52M
derived: sum of 3 quarters · filed 2012-05-10
$3.52M
derived: sum of 4 quarters · filed 2012-05-10
2011-03-31$546.00K
10-Q · filed 2012-05-10
$1.99M
derived: sum of 2 quarters · filed 2012-05-10
$1.98M
derived: sum of 3 quarters · filed 2012-05-10
$5.18M
derived: sum of 4 quarters · filed 2012-05-10
2010-12-31$1.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$1.43M
derived: sum of 2 quarters · filed 2012-02-29
$4.64M
derived: sum of 3 quarters · filed 2012-02-29
$5.67M
10-K · filed 2012-02-29
2010-09-30-$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$3.19M
derived: sum of 2 quarters · filed 2011-11-09
$4.23M
10-Q · filed 2011-11-09
$5.64M
derived: sum of 4 quarters · filed 2012-02-29
2010-06-30$3.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02
$4.24M
10-Q · filed 2011-08-02
$5.65M
derived: sum of 3 quarters · filed 2012-02-29
$122.21M
derived: sum of 4 quarters · filed 2012-02-29
2010-03-31$1.04M
10-Q · filed 2011-05-10
$2.45M
derived: sum of 2 quarters · filed 2012-02-29
$119.00M
derived: sum of 3 quarters · filed 2012-02-29
2009-12-31$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$117.97M
derived: sum of 2 quarters · filed 2012-02-29
$119.99M
10-K · filed 2012-02-29
2009-09-30$116.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08
$118.58M
10-Q · filed 2010-11-08
2009-06-30$2.02M
10-Q · filed 2010-08-06
2008-12-31$7.05M
10-K · filed 2011-03-01